Stocktoria

REVELATION BIOSCIENCES, INC. REVB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-10-08 · LEI

REVELATION BIOSCIENCES, INC. statistics & valuation

Market cap$3.8M
P / B0.4×
Return on equity-100.6%
Return on capital-94.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-1029.00% -1.80% -319.40% -100.60% 2019202020212022202320242025
Shares outstanding
0 2.4M 282039 77375 16484 43526 1.6M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-16.00% -2.20% -587.00% -196.80% -1.00% -227.10% -77.00% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$42.50 -$149.20 -$8.44 -$1052.16 -$23.95 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-77.0%-227.1%-1.0%-196.8%-587.0%-2.2%-16.0%
Return on equity-100.6%-319.4%-1.8%-1029.0%153.2%28.6%100.0%
Current ratio5.413.432.181.220.890.190.86

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.